Microbot Medical Inc. (MBOT): Price and Financial Metrics


Microbot Medical Inc. (MBOT): $7.39

0.47 (+6.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

MBOT Stock Price Chart Interactive Chart >

Price chart for MBOT

MBOT Price/Volume Stats

Current price $7.39 52-week high $10.69
Prev. close $6.92 52-week low $6.31
Day low $6.87 Volume 81,000
Day high $7.40 Avg. volume 111,203
50-day MA $7.21 Dividend yield N/A
200-day MA $7.77 Market Cap 52.53M

Microbot Medical Inc. (MBOT) Company Bio


Microbot Medical Inc. operates as a medical device company. The Company specializes in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Microbot Medical offers its services in the United States.


MBOT Latest News Stream


Event/Time News Detail
Loading, please wait...

MBOT Latest Social Stream


Loading social stream, please wait...

View Full MBOT Social Stream

Latest MBOT News From Around the Web

Below are the latest news stories about Microbot Medical Inc that investors may wish to consider to help them evaluate MBOT as an investment opportunity.

Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of ''One & Done'' Technology

HINGHAM, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT ) announced that China has become the latest global jurisdiction to issue a Notice of Allowance (NOA) for the Company''s innovative One & Done'' guidewire technology, joining the European Union along with those received earlier this year from Japan and Israel. Globally, the Company now holds a total of 44 patents issued/allowed and 24 pending patent applications. "This latest patent allowance will expand protection of our One & Done technology, while we pursue solutions that provide better patient outcomes and healthcare economics," commented Harel Gadot, CEO, President and Chairman. "We secured three patents in the last year that we believe have strengthened our place in large addressable markets, and...

Benzinga | June 29, 2021

Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of One & Done Technology

HINGHAM, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that China has become the latest global jurisdiction to issue a Notice of Allowance (NOA) for the Companys innovative One & Done guidewire technology, joining the European Union along with those received earlier this year from Japan and Israel. Globally, the Company now holds a total of 44 patents issued/allowed and 24 pending patent applications.

Intrado Digital Media | June 29, 2021

Microbot Medical Secures Patent Allowance in China; Third Global Jurisdiction in 2021 to Recognize Novelty of ‘One & Done’ Technology

HINGHAM, Mass., June 29, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that China has become the latest global jurisdiction to issue a Notice of Allowance (NOA) for the Company’s innovative ‘One & Done’ guidewire technology, joining the European Union along with those received earlier this year from Japan and Israel. Globally, the Company now holds a total of 44 patents issued/allowed and 24 pending patent applications. “This latest patent allowance will expand protecti

Yahoo | June 29, 2021

Here's Why We're Not Too Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Yahoo | June 26, 2021

Microbot Medical (MBOT) Receives a Buy from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. The post Microbot Medical (MBOT) Receives a Buy from H.C. Wainwright appeared first on Smarter Analyst .

Smarter Analyst | June 8, 2021

Read More 'MBOT' Stories Here

MBOT Price Returns

1-mo -3.90%
3-mo -5.26%
6-mo -13.26%
1-year -3.52%
3-year 20.16%
5-year -96.00%
YTD 7.26%
2020 -32.25%
2019 491.28%
2018 -88.76%
2017 -83.28%
2016 -86.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9091 seconds.